• Sectors
    • Tech
    • Healthcare
    • Consumer
    • Energy
    • Mining & Metals
    • Business Services
    • Financials
    • Telecom
    • Industrials
    • Transportation
    • Aerospace & Defense
    • Real Estate
    • Utilities
  • Spotlight Stocks
  • CEO Interview
    • Investor Presentations
  • Newsmakers
  • Investing Strategy
    • Analyst Reports
    • Insider Trading
    • Smart Money
  • Funds & ETF’s
  • Markets
    • Commodities
    • Currencies
    • Economy
    • Lending & Interest Rates
  • Business News
    • Trading Ideas
  • Executive Resources
    • Leadership & Strategy
    • Capital
    • Law
  • Investor Education
    • Long Term Investing
    • Personal Finance
    • Stock Trading
    • Options Trading
    • Forex Trading
    • Futures Trading
  • Members
Newswire
  • [ March 23, 2019 ] Turkish watchdogs to probe JP Morgan after lira plunge Business News
  • [ March 23, 2019 ] Turkish watchdog to investigate JP Morgan, other banks: Anadolu Business News
  • [ March 23, 2019 ] U.S. airlines prepare for 737 MAX tests, Southwest parks jets near desert Business News
  • [ March 23, 2019 ] Ex-Autonomy CEO Lynch denies new U.S. charges against him Business News
  • [ March 23, 2019 ] U.S.’s Lighthizer, Mnuchin to travel to China for trade talks: White House Business News
  • [ March 23, 2019 ] Indian state open for talks with Uber rival Ola over ban Business News
  • [ March 23, 2019 ] The Student Debt Crisis and What It Means for You Trading Ideas
  • [ March 23, 2019 ] Citi fires eight Hong Kong traders after review finds misconduct: sources Business News
  • [ March 23, 2019 ] Apple’s Cook to China: keep opening for sake of global economy Business News
  • [ March 23, 2019 ] AT&T, Viacom continue contract negotiations past deadline Business News
HomeHealthcareHow to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks

March 11, 2018 admin Healthcare, Investor Education Comments Off on How to Trade Biotech and Pharmaceutical Stocks

How to Trade Biotech and Pharmaceutical Stocks
Profiting from the FDA approval cycle

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati




Previous

Exelixis (NASDAQ: EXEL) CEO Michael Morrissey gives an update on cabozantinib

Next

Rick Rule on Gold and Contrarian Stock Picks for 2018

Featured Stocks

newsmakers

  • Nightfood Ice Cream (OTC: NGTF) Scores Two Major National Media Hits: CEO Interviewed on Yahoo Finance PM, and a Feature on Today.com
    March 21, 2019 Comments Off on Nightfood Ice Cream (OTC: NGTF) Scores Two Major National Media Hits: CEO Interviewed on Yahoo Finance PM, and a Feature on Today.com
  • CytoDyn (OTC: CYDY) Reaches Historical Milestone, Submits First of Three Sections of BLA to FDA for Leronlimab (PRO 140) as a Combination Therapy for HIV
    March 21, 2019 Comments Off on CytoDyn (OTC: CYDY) Reaches Historical Milestone, Submits First of Three Sections of BLA to FDA for Leronlimab (PRO 140) as a Combination Therapy for HIV
  • Medicine Man Technologies, Inc., (OTC: MDCL) to Present at Sidoti & Company,Spring 2019 Conference
    March 21, 2019 Comments Off on Medicine Man Technologies, Inc., (OTC: MDCL) to Present at Sidoti & Company,Spring 2019 Conference
  • CytoDyn (OTC: CYDY)Reports Significant Reduction in Breast Cancer Tumor Metastasis in Preclinical Study and Requests FDA Fast Track Designation for Leronlimab (PRO 140) in Metastatic-Triple Negative Breast Cancer (mTNBC)
    March 12, 2019 Comments Off on CytoDyn (OTC: CYDY)Reports Significant Reduction in Breast Cancer Tumor Metastasis in Preclinical Study and Requests FDA Fast Track Designation for Leronlimab (PRO 140) in Metastatic-Triple Negative Breast Cancer (mTNBC)
  • Nightfood Ice Cream (OTC: NGTF) Expanding Distribution to Sixteen States; Second Production Run This Week, Initial Feedback is Strong
    March 11, 2019 Comments Off on Nightfood Ice Cream (OTC: NGTF) Expanding Distribution to Sixteen States; Second Production Run This Week, Initial Feedback is Strong
  • FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)
    March 7, 2019 Comments Off on FDA Grants Rolling Review for CytoDyn’s (OTC: CYDY) Planned BLA for Investigational HIV Therapy Leronlimab (PRO 140)
LEADERS

NightFood Holdings, Inc. (OTC: NGTF) Is this the next Billion Dollar Brand?

Medicine Man Technologies (OTC: MDCL) Cannabis operator on track for $40 mil revenues (and profits) with new acquisitions

(VIDEO) Cobalt27 (TSX.V: KBLT) “pure play” on electric vehicle boom

CytoDyn (OTC: CYDY) Monoclonal antibody HIV treatment w potential FDA approval in 2019

Medicine Man Technologies (OTC: MDCL) Vertically integrated cannabis operator, with growing revenues and profits

Cobalt27 (TSX.V: KBLT) (OTC: CBLLF) A “pure play” on electric vehicle boom

CytoDyn Inc. (OTC: CYDY) Monoclonal antibody for treating HIV and Cancer. Potential FDA approval for HIV in 2019

Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

FSD Pharma, Inc (CSE: HUGE) (OTC: FSDDF) Building world’s largest indoor cannabis grower.

CellCube Energy Systems (OTC: CECBF) “$100 Million Sales Pipeline 2019”

  • Contact
  • About Us
  • Investor Relations Services
  • Terms of Use/Legal Notice
  • Become a Newsmaker
  • Login
  • Newsmakers Account
    • Subscriptions
    • Submit Press Release

Copyright © 2019 | MH Magazine WordPress Theme by MH Themes